| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |